Almac Clinical Technologies Named “Best Clinical Trial Technology Solution Provider” in 2026 MedTech Breakthrough Awards Programme
May 7, 2026
10th Annual Awards Programme Recognises the Most Innovative Digital Health and Medical Technology Solutions Worldwide
Almac Clinical Technologies today announced that it has been selected as winner of the “Best Clinical Trial Technology Solution Provider” award in the 10th annual MedTech Breakthrough Awards programme conducted by MedTech Breakthrough, an independent market intelligence organisation that recognises the most innovative companies, technologies and products in the global digital health and medical technology market.
Almac earned the recognition for not only its broad commitment to advancing clinical trial execution through integrated technology, operational expertise and global support capabilities, but also for the impact of the company’s breakthrough new platform, Almac Trial Coordinator™.
Almac Trial Coordinator™ was introduced in 2025, delivering a next-generation orchestration solution that unifies the operational journey of a clinical trial, bringing together tasks, data, systems, and people into a single, intuitive experience. It features a role-based, multi-modal interface that presents accurate information to the correct user at the right moment.
Sites have the ability to consolidate visit windows, patient status, eCOA compliance, drug accountability, and study tasks, while sponsors and CROs gain oversight through intelligent dashboards, alerts, and predictors, enabling proactive decision-making.
In line with Almac’s integrated approach to trial technology, Almac Trial Coordinator™ offers seamless interoperability with Almac’s global IRT platform and with third-party systems, ensuring real-time data synchronisation and equipping teams with up-to-date operational information wherever needed. Early deployments have shown reduced site burden, fewer protocol deviations, more consistent data collection, and enhanced oversight.
“Our years of Clinical Trial Technology delivery and support experience have informed every component of the platform – from user experience to compliance safeguards. Almac Trial Coordinator™ is reliable in environments where precision, auditability, and regulatory alignment matter most. We are delighted to be recognised by MedTech Breakthrough for the impact Almac Trial Coordinator will continue to have on crucial studies and the patients that rely on them,” said Valarie Higgins, President and Managing Director of Almac Clinical Technologies.
Now celebrating its 10th anniversary, the MedTech Breakthrough Awards programme has spent a decade recognising the companies driving meaningful progress and improving patient care across the global health and medical technology industry. The programme spans a wide range of categories – including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices and beyond – honouring the innovations reshaping how care is delivered worldwide.
This year’s programme drew a record-breaking number of nominations from leading companies and startups across more than 20 countries, reflecting the growing global impact and momentum of the digital healthcare industry.
“Combining interoperability, automation, and user-centred design, Almac Trial Coordinator sets a new benchmark for how modern trials should be managed. The disconnect across individual technologies like eCOA, IRT, and more forces sites and study teams to rely on manual workarounds, duplicated data entry, and error-prone processes, slowing down studies, burdening sites, and complicating operational oversight,” said Steve Johansson, managing director, MedTech Breakthrough. “Almac Clinical Technologies delivers something genuinely transformative: a unified operational command centre designed to simplify, streamline, and elevate the clinical trial experience for all stakeholders. We’re pleased to award Almac Group with ‘Best Clinical Trial Technology Solution Provider!’”
Share
